Contributors
Andrea Abati(National Institutes of Health), Marshall E. Kadin(University of Minnesota), Lyn M. Duncan(Massachusetts General Hospital), Kathryn Foucar(University of New Mexico), Miroslav Djokic, Philippe Gaulard(Inserm), Todd Barry, Judith A. Ferry(Harvard University), Wing C. Chan(Ontario Institute for Cancer Research), R.S.K. Chaganti, Nancy L. Harris(World Resources Institute), Kojo S.J. Elenitoba‐Johnson(Memorial Sloan Kettering Cancer Center), Joseph M. Connors, R. Hutchison(SUNY Upstate Medical University), Armando Filie(National Institutes of Health), Eric D. Hsi(Mayo Clinic), Karen Chang(City Of Hope National Medical Center), Robert P. Hasserjian(Massachusetts General Hospital), Elı́as Campo(Hospital Clínic de Barcelona), Falko Fend(Universitätsklinikum Tübingen), Çiğdem Atayar, Randy D. Gascoyne(BC Cancer Agency), Ronald Jaffe(Stanford University), Timothy C. Greiner(University of Nebraska Medical Center), Fiona E. Craig(The University of Texas at San Antonio Health Science Center), Wah Cheuk, Jane Houldsworth(Icahn School of Medicine at Mount Sinai), Pierre Brousset(Université Toulouse III - Paul Sabatier), Amy Heerema‐McKenney(Stanford University), Barbara J. Bain(St Mary's Hospital), Juan F. Garcı́a(MD Anderson Cancer Center Madrid), Dan Jones(The Ohio State University Wexner Medical Center), Daniel A. Arber(University of Chicago), Alexander Chan(Memorial Sloan Kettering Cancer Center), Fabio Facchetti(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Georges Delsol(Inserm), Adam Bagg(University of Pennsylvania), Miguel Ángel de la Cruz Mora, Elaine S. Jaffe(National Cancer Institute), David R. Head(University of Southern California), John K. C. Chan(Unknown), Peter G. Isaacson, Francisca I. Camacho, Hans‐Peter Horny(Ludwig-Maximilians-Universität München), Michael J. Borowitz(Johns Hopkins University), Katherine S. Hamilton, Russell K. Brynes, Pedro Jares(Hospital Clínic de Barcelona), Ignacio Fernández Chacón, Elizabeth Hyjek(University of Chicago)
Cited by 0
Related Papers
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
|Blood|2016|10.2k
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
|Nature|2000|10k
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
|Blood|2009|4.4k
The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma
|New England Journal of Medicine|2002|3.9k